Panel presentation of Genetic Treatment Strategies for Hearing Loss

This session explores the cutting-edge frontier of inner ear therapeutics. We will cover groundbreaking innovations, including gene therapy for hereditary deafness, regenerative medicine for hair cell restoration, and novel drug delivery systems for treating hearing and balance disorders.

Outcome Objectives Participants will be able to:

1. Describe emerging gene and cell-based strategies for hearing restoration.

2. Evaluate the potential of next-generation cochlear and vestibular implants.

3. Identify new pharmacological targets and delivery methods for the inner ear.

Background Sensorineural hearing loss and vestibular disorders have long been considered irreversible. Advances in molecular biology and bioengineering are now challenging this paradigm, creating unprecedented opportunities for biological repair and functional restoration of the inner ear.

Description

This session highlights the latest research and innovation in ear and hearing science, aligned with the mission of the Mirko Tos Ear & Hearing Research Center. We explore cutting-edge developments, ranging from molecular biomarkers for early diagnosis to minimally invasive surgical techniques. Key topics include novel auditory implants, tinnitus management strategies, and translational research on inner ear pathophysiology. By bringing together audiologists, surgeons, and basic scientists, we aim to accelerate the development of personalized therapies for complex auditory and vestibular disorders.

Outcome Objectives

Upon completion, participants will be able to:

1. Identify emerging trends in middle ear surgery and hearing rehabilitation technologies.

2. Evaluate the clinical utility of new diagnostic biomarkers for sensorineural hearing loss and tinnitus.

3. Apply multidisciplinary, evidence-based strategies to improve patient outcomes in the management of chronic ear disease and vestibular dysfunction.

Rare Conditions panel discussion general